Joseph J. Villafranca
President bij Biopharmaceutical Consultants LLC
Actieve functies van Joseph J. Villafranca
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Anima Cell Metrology, Inc.
Anima Cell Metrology, Inc. Packaged SoftwareTechnology Services Anima Cell Metrology, Inc. engages in the development of novel technologies to monitor protein synthesis in living cells. The company was founded by Zeev Smilansky and is headquartered in Bernardsville, NJ. | Directeur/Bestuurslid | 11-10-2010 | - |
Biopharmaceutical Consultants LLC | President | 01-05-2012 | - |
Loopbaan van Joseph J. Villafranca
Eerdere bekende functies van Joseph J. Villafranca
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IMMUNOGEN, INC. | Directeur/Bestuurslid | 01-06-2004 | 20-06-2018 |
Independent Dir/Board Member | 01-06-2004 | 20-06-2018 | |
Tunnell Consulting, Inc.
Tunnell Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Tunnell Consulting, Inc. provides technical, organizational and operational consulting services. It provides life sciences technical services, process and organizational excellence services, strategy and supply chain management services. The firm serves in the area of pharmaceutical, government and biotechnology departments. The company was founded in 1962 and is headquartered in King of Prussia, PA. | Directeur/Bestuurslid | 11-10-2010 | 17-11-2011 |
Operationeel Directeur | 01-05-2006 | 17-11-2011 | |
Corporate Officer/Principal | 17-11-2011 | 01-04-2012 | |
Biopharmaceutical Consultants LLC | President | 01-01-2005 | 01-01-2006 |
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Operationeel Directeur | 01-01-2002 | 31-10-2005 |
Bristol-Myers Squibb World Wide Medicines Group
Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Corporate Officer/Principal | - | - |
The Pennsylvania State University | Corporate Officer/Principal | - | - |
Opleiding van Joseph J. Villafranca
Purdue University | Doctorate Degree |
The State University of New York | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Chief Operating Officer | 2 |
Sectoraal
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Health Technology |
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Tunnell Consulting, Inc.
Tunnell Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Tunnell Consulting, Inc. provides technical, organizational and operational consulting services. It provides life sciences technical services, process and organizational excellence services, strategy and supply chain management services. The firm serves in the area of pharmaceutical, government and biotechnology departments. The company was founded in 1962 and is headquartered in King of Prussia, PA. | Commercial Services |
Biopharmaceutical Consultants LLC | |
Bristol-Myers Squibb World Wide Medicines Group
Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Health Technology |
Anima Cell Metrology, Inc.
Anima Cell Metrology, Inc. Packaged SoftwareTechnology Services Anima Cell Metrology, Inc. engages in the development of novel technologies to monitor protein synthesis in living cells. The company was founded by Zeev Smilansky and is headquartered in Bernardsville, NJ. | Technology Services |